Publications

BJC reports

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.

03-06-2026

Genome medicine

The contribution of rare germline variants to the immune landscape of breast cancer.

09-05-2026

NPJ breast cancer

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

06-05-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

21-04-2026

Journal of medical genetics

Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study.

20-04-2026

Breast cancer research : BCR

Exercise effects on lean body mass, muscle strength and functional performance in patients with metastatic breast cancer: the randomized controlled PREFERABLE-EFFECT study.

13-04-2026

iScience

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

20-02-2026

International journal of cancer

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

15-02-2026

Breast (Edinburgh, Scotland)

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

01-02-2026

Breast (Edinburgh, Scotland)

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

01-02-2026

Breast (Edinburgh, Scotland)

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

01-02-2026

BMC medical ethics

Implementing broad consent for research with routinely collected clinical data and residual biosamples in a cancer hospital: using mixed methods approach to evaluate consent rates and patients' perspectives.

09-01-2026

Trials

Effects of personalized live-remote exercise for individuals living beyond primary curative cancer treatment: study protocol for a multinational, super umbrella randomized controlled trial (LION-RCT).

24-11-2025

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.

03-11-2025

NPJ breast cancer

Predicting short- to long-term breast cancer risk from longitudinal mammographic screening history.

29-10-2025

Breast (Edinburgh, Scotland)

Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.

01-10-2025

Nature communications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

08-09-2025

Journal of the National Cancer Institute. Monographs

Considerations for delivery of live-remote exercise for people with cancer in research and practice.

01-09-2025

International journal of cancer

Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.

01-08-2025

Cancer medicine

Factors Associated With Employment and Quality of Working Life in Patients With Metastatic Breast Cancer.

01-08-2025

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.

01-08-2025

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Exercise effects on symptoms of depression and anxiety vary by patient, clinical, and intervention characteristics in cancer survivors: Results from pooled analyses of individual participant data of 26 RCTs.

01-07-2025

JAMA network open

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.

01-07-2025

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.

03-06-2025

Breast (Edinburgh, Scotland)

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

01-06-2025

Nature communications

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

25-05-2025

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.

10-04-2025

MDM policy & practice

Bridging the Gap: A Mixed-Methods Study on Factors Influencing Breast Cancer Clinicians' Decisions to Use Clinical Prediction Models.

28-03-2025

NPJ breast cancer

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.

19-02-2025

Breast cancer research and treatment

Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant.

01-02-2025

Breast (Edinburgh, Scotland)

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.

01-02-2025

Nature medicine

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

01-01-2025

Breast cancer research : BCR

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

29-12-2024

Journal of the National Cancer Institute

Risk factors for breast cancer subtypes by race and ethnicity: a scoping review.

01-12-2024

BMJ open

Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2.

09-10-2024

Journal of cancer survivorship : research and practice

Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis.

01-10-2024

Nature medicine

Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial.

01-10-2024

Key Publication

American journal of human genetics

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

05-09-2024

medRxiv : the preprint server for health sciences

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

04-09-2024

Genetics in medicine : official journal of the American College of Medical Genetics

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

01-09-2024

Gynecologic oncology

Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.

01-08-2024

Nature genetics

Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

01-08-2024

Journal of medical genetics

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

19-07-2024

Nature genetics

Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

01-07-2024

Cancer discovery

Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.

01-07-2024

Bioinformatics advances

Assessing the validity of driver gene identification tools for targeted genome sequencing data.

29-05-2024

medRxiv : the preprint server for health sciences

Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature.

19-03-2024

ESMO open

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.

01-03-2024

medRxiv : the preprint server for health sciences

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

13-02-2024

Scandinavian journal of medicine & science in sports

Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study.

01-02-2024

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.

The contribution of rare germline variants to the immune landscape of breast cancer.

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study.

Exercise effects on lean body mass, muscle strength and functional performance in patients with metastatic breast cancer: the randomized controlled PREFERABLE-EFFECT study.

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

Implementing broad consent for research with routinely collected clinical data and residual biosamples in a cancer hospital: using mixed methods approach to evaluate consent rates and patients' perspectives.

Effects of personalized live-remote exercise for individuals living beyond primary curative cancer treatment: study protocol for a multinational, super umbrella randomized controlled trial (LION-RCT).

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.

Predicting short- to long-term breast cancer risk from longitudinal mammographic screening history.

Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Considerations for delivery of live-remote exercise for people with cancer in research and practice.

Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.

Factors Associated With Employment and Quality of Working Life in Patients With Metastatic Breast Cancer.

Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.

Exercise effects on symptoms of depression and anxiety vary by patient, clinical, and intervention characteristics in cancer survivors: Results from pooled analyses of individual participant data of 26 RCTs.

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.

Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.

Bridging the Gap: A Mixed-Methods Study on Factors Influencing Breast Cancer Clinicians' Decisions to Use Clinical Prediction Models.

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.

Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant.

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Risk factors for breast cancer subtypes by race and ethnicity: a scoping review.

Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2.

Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis.

Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial.

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.

Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.

Assessing the validity of driver gene identification tools for targeted genome sequencing data.

Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature.

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study.

This site uses cookies